Johnson Investment Counsel’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.12M Buy
20,570
+1,045
+5% +$159K 0.03% 215
2025
Q1
$2.94M Sell
19,525
-417
-2% -$62.8K 0.03% 221
2024
Q4
$3.68M Sell
19,942
-1,845
-8% -$341K 0.04% 188
2024
Q3
$4.29M Sell
21,787
-860
-4% -$169K 0.04% 173
2024
Q2
$4.68M Buy
22,647
+1,966
+10% +$406K 0.05% 161
2024
Q1
$5.6M Sell
20,681
-1,651
-7% -$447K 0.06% 152
2023
Q4
$5.28M Buy
22,332
+2,565
+13% +$606K 0.06% 149
2023
Q3
$3.87M Buy
19,767
+2,650
+15% +$519K 0.05% 168
2023
Q2
$3.6M Sell
17,117
-265
-2% -$55.7K 0.04% 171
2023
Q1
$3.51M Buy
17,382
+2,090
+14% +$422K 0.05% 171
2022
Q4
$3.33M Sell
15,292
-314
-2% -$68.4K 0.05% 172
2022
Q3
$3.07M Sell
15,606
-236
-1% -$46.4K 0.05% 171
2022
Q2
$3.39M Sell
15,842
-422
-3% -$90.3K 0.05% 163
2022
Q1
$4.62M Sell
16,264
-308
-2% -$87.5K 0.06% 156
2021
Q4
$6.24M Buy
16,572
+569
+4% +$214K 0.08% 134
2021
Q3
$6.6M Sell
16,003
-1,088
-6% -$449K 0.09% 125
2021
Q2
$6.32M Buy
17,091
+85
+0.5% +$31.4K 0.09% 125
2021
Q1
$4.93M Buy
17,006
+2,920
+21% +$846K 0.07% 136
2020
Q4
$3.52M Buy
14,086
+21
+0.1% +$5.25K 0.06% 150
2020
Q3
$3.19M Sell
14,065
-1,168
-8% -$264K 0.06% 151
2020
Q2
$2.66M Sell
15,233
-921
-6% -$161K 0.05% 159
2020
Q1
$2.04M Sell
16,154
-1,215
-7% -$153K 0.05% 172
2019
Q4
$2.65M Sell
17,369
-50
-0.3% -$7.64K 0.05% 177
2019
Q3
$2.31M Buy
17,419
+2,679
+18% +$355K 0.05% 182
2019
Q2
$2.09M Buy
14,740
+4,705
+47% +$667K 0.04% 193
2019
Q1
$1.46M Hold
10,035
0.03% 245
2018
Q4
$1.14M Sell
10,035
-1,855
-16% -$210K 0.03% 270
2018
Q3
$1.6M Buy
+11,890
New +$1.6M 0.04% 238